Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Review

Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide

       
Total article views   HTML views PDF downloads Totals
13,529 Dovepress* 13,529+ 3,071 16,600
Totals 13,529 3,071 16,600
*Since 31 August 2010
+Since July 2016

View citations on Google Scholar